| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8441214 | European Journal of Cancer | 2016 | 11 Pages |
Abstract
These results indicate that peptide receptor radionuclide therapy is a highly effective therapy for patients with low to intermediate grade neuroendocrine neoplasms with minor adverse events.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Dieter Hörsch, Samer Ezziddin, Alexander Haug, Klaus Friedrich Gratz, Simone Dunkelmann, Matthias Miederer, Mathias Schreckenberger, Bernd Joachim Krause, Frank M. Bengel, Peter Bartenstein, Hans-Jürgen Biersack, Gabriele Pöpperl, R.P. Baum,